Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
DEXILANT TAKEDA CANADA INC Resolved 30MG Updated Report 2024-05-16 223152
TRIFLUOPERAZINE AA PHARMA INC Actual shortage 5MG New Report 2024-05-16 228173
SUPREFACT DEPOT 3 MONTHS CHEPLAPHARM ARZNEIMITTEL GMBH Actual shortage 9.45MG Updated Report 2024-05-16 207981
ANANDRON CHEPLAPHARM ARZNEIMITTEL GMBH Actual shortage 50MG Updated Report 2024-05-16 204346
FLOLAN GLAXOSMITHKLINE INC Actual shortage 1.5MG Updated Report 2024-05-16 220338
VIIBRYD ABBVIE CORPORATION Anticipated shortage 20MG New Report 2024-05-16 228152
TEVA-CYCLOSPORINE TEVA CANADA LIMITED Actual shortage 0.05% New Report 2024-05-16 228149
RATIO-TOPISALIC TEVA CANADA LIMITED Actual shortage 20MG 0.5MG New Report 2024-05-16 228146
ACT METHYLPHENIDATE ER TEVA CANADA LIMITED Actual shortage 54MG New Report 2024-05-16 228143
TEVA-NAPROXEN TEVA CANADA LIMITED Actual shortage 500MG New Report 2024-05-16 228140

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
FOSRENOL TAKEDA CANADA INC To be discontinued 1000MG New Report 2024-05-16 228184
FOSRENOL TAKEDA CANADA INC To be discontinued 750MG New Report 2024-05-16 228181
FOSRENOL TAKEDA CANADA INC To be discontinued 500MG New Report 2024-05-16 228178
SUPREFACT DEPOT 2 MONTHS CHEPLAPHARM ARZNEIMITTEL GMBH To be discontinued 6.3MG New Report 2024-05-16 228169
SUPREFACT DEPOT 3 MONTHS CHEPLAPHARM ARZNEIMITTEL GMBH To be discontinued 9.45MG New Report 2024-05-16 228166